Sage Therapeutics Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	743	591	441	1,153	1,856	2,197
Market Cap Growth	29.23%	34.02%	-61.77%	-37.88%	-15.50%	-
Enterprise Value	942	878	704	1,308	1,937	-
Last Close Price	12.90	13.41	14.63	56.32	102.32	121.09
PE Ratio	-	-	-	-	-	387.41
PS Ratio	1.57	1.49	1.64	6.76	25.56	304.08
PB Ratio	2.83	3.79	1.96	6.53	6.00	5.66
P/TBV Ratio	2.86	3.83	1.98	6.60	6.16	5.75
EV/Sales Ratio	1.99	2.21	2.61	7.67	26.66	-
Debt / Equity Ratio	0.79	2.36	1.36	1.33	0.48	0.18
Debt / EBITDA Ratio	-	-	-	-	-	5.11
Asset Turnover	0.70	0.58	0.44	0.31	0.14	-
Inventory Turnover	51.69	33.24	35.54	50.01	1.23	-
Quick Ratio	0.23	0.14	0.21	0.16	0.69	35.10
Current Ratio	1.27	0.85	1.09	0.87	2.78	52.85
Return on Equity (ROE)	-77.02%	-123.39%	-122.64%	-122.33%	-21.55%	-
Return on Assets (ROA)	-16.05%	-16.08%	-21.27%	-31.97%	-8.01%	-
Return on Capital (ROIC)	-19.42%	-20.87%	-27.91%	-40.38%	-8.94%	-
Return on Capital Employed (ROCE)	-	-	-	-	-	2.30%
Earnings Yield	-30.91%	-39.78%	-55.84%	-25.77%	-4.05%	0.26%
FCF Yield	-22.39%	-34.10%	-57.98%	-20.71%	-7.72%	-7.47%
Buyback Yield / Dilution	-	-71.92%	-21.78%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.